The force level of mutant myosin molecules correlates with the clinical prognosis of human familial hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Myosin force levels may predict HCM severity in models; leaves open human validation and therapeutic translation.
Fujita et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: